Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation-Reference-Cited by-同舟云学术

Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation

Published:2021-07-14 Issue:8 Volume:19 Page:1874-1882
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J. Thromb. Haemost.

Author:

Martin Karlyn A.¹,Beyer‐Westendorf Jan²,Davidson Bruce L.³,Huisman Menno V.⁴,Sandset Per Morten⁵^ORCID,Moll Stephan⁶

Affiliation:

1. Division of Hematology/Oncology Department of Medicine Northwestern University Feinberg School of Medicine Chicago IL USA

2. Thrombosis Research Unit, Division Hematology and Hemostasis Department of Medicine 1 University Hospital Technische University Dresden Dresden Germany

3. Pulmonary and Critical Care Medicine Washington State University Elson S Floyd College of Medicine and Providence Health System Seattle WA USA

4. Department of Thrombosis and Hemostasis Leiden University Medical Center Leiden the Netherlands

5. Department of Hematology Oslo University Hospital and University of Oslo Oslo Norway

6. Division of Hematology Department of Medicine University of North Carolina Chapel Hill NC USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15358

Reference49 articles.

1. World Health Organization.“Obesity and overweight ” 2018. Available athttps://www.who.int/news‐room/fact‐sheets/detail/obesity‐and‐overweight‐:~:text=Some%20recent%20WHO%20global%20estimates years%20and%20older%20were%20overweight.&text=In%202016%2C%2039%25%20of%20adults women)%20were%20obese%20in%202016. Accessed 28 Oct 2020.

2. Antithrombotic Therapy for VTE Disease

3. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

4. Obesity and cardiovascular disease: revisiting an old relationship

5. Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? – A population pharmacokinetic analysis;Thrombosis Research;2024-10

2. Hämatologische und onkologische Notfälle;TumorDiagnostik & Therapie;2024-09

3. Unresolved questions on venous thromboembolic disease. Venous thromboembolism (VTE) management in obese patients. Consensus statement of the French Society of Vascular Medicine (SFMV);JMV-Journal de Médecine Vasculaire;2024-09

4. Obesity and cardiovascular disease: an ESC clinical consensus statement;European Journal of Preventive Cardiology;2024-08-30

5. Practical Prescribing: Direct oral anticoagulants;BMJ;2024-08-30